Cargando…
CCL2 deficient mesenchymal stem cells fail to establish long-lasting contact with T cells and no longer ameliorate lupus symptoms
Systemic lupus erythematosus (SLE) is a multi-organ autoimmune disease characterized by autoantibody production. Mesenchymal stem cells (MSCs) ameliorate SLE symptoms by targeting T cells, whereas the mechanisms of their efficacy remain incompletely understood. In this study, we show that transfer o...
Autores principales: | Lee, Hong Kyung, Kim, Hyung Sook, Kim, Ji Sung, Kim, Yong Guk, Park, Ki Hwan, Lee, Jae Hee, Kim, Ki Hun, Chang, In Young, Bae, Sang-Cheol, Kim, Youngsoo, Hong, Jin Tae, Kehrl, John H., Han, Sang-Bae |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5259742/ https://www.ncbi.nlm.nih.gov/pubmed/28117437 http://dx.doi.org/10.1038/srep41258 |
Ejemplares similares
-
Mesenchymal stem cells enhance CCL8 expression by podocytes in lupus-prone MRL.Fas(lpr) mice
por: Kim, Hyung Sook, et al.
Publicado: (2023) -
Effect of a Combination of Prednisone or Mycophenolate Mofetil and Mesenchymal Stem Cells on Lupus Symptoms in MRL.Fas(lpr) Mice
por: Lee, Hong Kyung, et al.
Publicado: (2018) -
Effect of Human Mesenchymal Stem Cells on Xenogeneic T and B Cells Isolated from Lupus-Prone MRL.Fas(lpr) Mice
por: Lee, Hong Kyung, et al.
Publicado: (2020) -
Phorbol ester activates human mesenchymal stem cells to inhibit B cells and ameliorate lupus symptoms in MRL.Fas(lpr) mice
por: Lee, Hong Kyung, et al.
Publicado: (2020) -
Adoptive Cell Therapy of Melanoma with Cytokine-induced Killer Cells
por: Kim, Ji Sung, et al.
Publicado: (2015)